FDA Inspection 1014353 — Cardiocommand Inc.

Cardiocommand Inc. — FEI 1927197

The FDA completed an inspection of Cardiocommand Inc. on May 17, 2017 in Tampa, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 17, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Compliance: Devices
Location
Tampa, FL (United States)

Citations

IDCFRDescription
313021 CFR 820.100(a)Lack of or inadequate procedures
63021 CFR 803.17Lack of Written MDR Procedures